216 It is known that changes in GFR can affect the elimination of many drugs including narrow therapeutic index drugs (aminoglycosides, lithium, digoxin), diuretics, and nonsteroidal anti-inflammatory drugs
Tirzepatide cardiovascular event risk assessment: a prespecified metaanalysis
[DOI] [PMC free article] [PubMed] [Google Scholar] 172.Alrubaye A., Motovali-Bashi M., Miroliaei M
Outcomes We performed post hoc analyses for cardiovascular outcomes including time to first composite 3-point MACE, individual MACE components, metabolic outcomes (change from baseline in HbA 1c and reduction from baseline in body weight), and safety outcomes (severe hypoglycemic episodes and serious AEs)
Aimovig (erenumab-aooe) injection
We hypothesize that reduced CPT-I activity may contribute to persistent fatigue in these congenital hypothyroid patients, even after levothyroxine therapy, which alone may be insufficient to fully address the downstream metabolic consequences of TPO and TSHR gene mutations present in this cohort